| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |